Id say any lifeline would be in the form of a relaxed Symbio/MNF agreement where the $2mill owing would be converted into a long term debt that ranks above shareholders. I have no problems with this since its an insurance policy for Symbio and smart business by the directors in protecting their core asset (and earning interest). I would do the same.
I would see it as a very bullish signal if they converted half of the Symbio debt into MNF equity (6.7million MNF shares and NO options at todays prices), include a structured and balanced repayment method for the balance and an ease on the payable amounts by MNF to Symbio. This would confirm to me they've got MNF cranking behind the scenes and they're ready to get the sp moving.
Bar the trade payables to Symbio - balance sheet looked pretty good to me, and a huge improvement on the previous year. Take out the 725K deferred revenue (not including costs) and it takes on a different view again.
MNF are being presented with opportunities atm which are falling 110% in their favour. If they grab them with two hands then MNF shareholders, Symbio and the directors will see a substantial return on investment imo. They have created a company with great products, a strong and growing client base, excellent service, an effective referral network and a very unique and marketable BRAND NAME.
Get Symbio related costs in check and enjoy the ride on MNF imo.
Cheers, The Sparkler
MNF Price at posting:
0.0¢ Sentiment: Buy Disclosure: Held